Study Casts Doubt on Prostate Cancer Test

PSA Levels May Be Inaccurate Indicators of Disease

The PSA blood test had been considered an accurate and easy method of screening for prostate cancer. National Cancer Institute hide caption

Graphic: Relationship Between PSA Levels and Cancer
itoggle caption National Cancer Institute
More on Prostate Cancer
» Fact Sheet on Prostate Cancer

» Q&A on the PSA (prostate-specific antigen) Test

Source: National Cancer Institute

Most American men over 50 get an annual blood test called a PSA — prostate-specific antigen — that is thought to indicate whether they may have prostate cancer. On a scale of zero to 10, doctors had thought that the level four or below was safe. Now researchers report in the New England Journal of Medicine that even men with a PSA below four may have a substantial risk of cancer.

The research was part of a $73 million study funded by the National Cancer Institute. It enrolled almost 19,000 men over 55. An analysis found that men with a PSA level formally considered safe still had a 15-percent risk of prostate cancer.

Study co-author Dr. Ian Thompson, of the University of Texas in San Antonio, said the most worrisome finding was that aggressive, or "high-grade," cancers were found at all levels of PSA; the researchers were unable to find a level of PSA below which there was no risk of prostate cancer. NPR's Richard Knox reports on the implications of the study.



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.